IP Library › Granted Patent US 10,822,627
Granted Patent B2
US 10,822,627 · App. 15/952,377 · Granted Nov 3, 2020

Mutants of hydantoinase

Inventors: Steffen Osswald (Nidderau, DE); Heiko Schuster (Hanau, DE); Jurgen Roos (Freigericht, DE); Andreas Karau (Geinhausen, DE); Ulrich Schwaneberg (Klemis-Hergenrath, BE); Ronny Martinez (Aachen, DE); Hemanshu Mundhada (Lyngby, DK); Ursula Holter (Willich, DE)
Assignee: Evonik Operations GmbH
C12P13/227C12N9/86C12P13/04C12P41/009C12Y305/02002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,822,627
App. No.
15/952,377
Granted
Nov 3, 2020
Kind
B2
Abstract

The present invention relates to a hydantoinase having an amino acid sequence selected from (i) or (ii), with (i) amino acid sequence selected from SEQ ID NO: 6-20 and SEQ ID NO: 73-119 (ii) amino acid sequence wherein in the amino acid sequence of SEQ ID NO: 6-20 and SEQ ID NO: 73-119, 1 to 75 amino acid residues have been substituted, deleted, inserted and/or added, and wherein further the catalytic activity of the hydantoinase is higher by a factor of at least 1.2 than the catalytic activity of the hydantoinase having amino acid sequence SEQ ID NO: 1. The present invention further relates to a process for preparing amino acids, wherein said hydantoinase is used.

Claims (8)

1. An isolated polynucleotide encoding an hydantoinase, wherein the catalytic activity of the hydantoinase encoded by the isolated polynucleotide is higher by a factor of at least 1.2 than the catalytic activity of an hydantoinase having the amino acid sequence of SEQ ID NO: 1, wherein the catalytic activity of an hydantoinase is the catalytic activity of the hydantoinase with respect to transformation of a 5-substituted D-hydantoin compound to the corresponding D-carbamoylamino acid, and wherein the isolated polynucleotide comprises a nucleotide sequence encoding an hydantoinase comprising an amino sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 20, SEQ ID NO: 85, SEQ ID NO: 86, SEQ ID NO: 88, SEQ ID NO: 89, SEQ ID NO: 90, SEQ ID NO: 91, SEQ ID NO: 92, SEQ ID NO: 93, SEQ ID NO: 94, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, SEQ ID NO: 100, SEQ ID NO: 101, SEQ ID NO: 102, SEQ ID NO: 103, SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO: 106, SEQ ID NO: 107, SEQ ID NO: 108, SEQ ID NO: 109, SEQ ID NO: 110, SEQ ID NO: 111, SEQ ID NO: 112, SEQ ID NO: 113, SEQ ID NO: 114, SEQ ID NO: 115, SEQ ID NO: 116, and SEQ ID NO: 117, or

an amino acid sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 20, SEQ ID NO: 85, SEQ ID NO: 86, SEQ ID NO: 88, SEQ ID NO: 89, SEQ ID NO: 90, SEQ ID NO: 91, SEQ ID NO: 92, SEQ ID NO: 93, SEQ ID NO: 94, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, SEQ ID NO: 100, SEQ ID NO: 101, SEQ ID NO: 102, SEQ ID NO: 103, SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO: 106, SEQ ID NO: 107, SEQ ID NO: 108, SEQ ID NO: 109, SEQ ID NO: 110, SEQ ID NO: 111, SEQ ID NO: 112, SEQ ID NO: 113, SEQ ID NO: 114, SEQ ID NO: 115, SEQ ID NO: 116, and SEQ ID NO: 117, wherein 1 to 50 amino acid residues have been substituted, deleted, inserted and/or added, and

wherein the amino acid substitutions present in the amino acid sequence of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 20, SEQ ID NO: 85, SEQ ID NO: 86, SEQ ID NO: 88, SEQ ID NO: 89, SEQ ID NO: 90, SEQ ID NO: 91, SEQ ID NO: 92, SEQ ID NO: 93, SEQ ID NO: 94, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, SEQ ID NO: 100, SEQ ID NO: 101, SEQ ID NO: 102, SEQ ID NO: 103, SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO: 106, SEQ ID NO: 107, SEQ ID NO: 108, SEQ ID NO: 109, SEQ ID NO: 110, SEQ ID NO: 111, SEQ ID NO: 112, SEQ ID NO: 113, SEQ ID NO: 114, SEQ ID NO: 115, SEQ ID NO: 116, and SEQ ID NO: 117, as compared to the amino acid sequence of SEQ ID NO: 1 are maintained.

2. A vector comprising the isolated polynucleotide of claim 1 .

3. A host cell comprising the isolated polynucleotide of claim 1 .

4. The host cell according to claim 3 , said host cell having at least the following enzymatic activities: hydantoinase and hydantoin racemase; hydantoinase and carbamoylase; or hydantoinase and hydantoin racemase and carbamoylase.

5. A host cell comprising a vector comprising the isolated polynucleotide of claim 1 .

6. The host cell of claim 5 , said host cell having at least the following enzymatic activities: hydantoinase and hydantoin racemase; hydantoinase and carbamoylase; or hydantoinase and hydantoin racemase and carbamoylase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2019
From: EVONIK INDUSTRIES AG
To: EVONIK TECHNOCHEMIE GMBH
Reel/Frame 051391/0482 →
MERGER AND CHANGE OF NAME Recorded Dec 31, 2019
From: EVONIK TECHNOCHEMIE GMBH; EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051391/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2019
From: OSSWALD, STEFFEN; SCHUSTER, HEIKO; ROOS, JURGEN; KARAU, ANDREAS; SCHWANEBERG, ULRICH; MARTINEZ, RONNY; MUNDHADA, HEMANSHU; HOLTER, URSULA
To: EVONIK INDUSTRIES AG
Reel/Frame 051450/0230 →
Priority Claims (1)
EP 11189395 · Nov 16, 2011 · regional
Continuity (2)
Division 14357028
Related Publication 20180237814A1 · Aug 23, 2018
Cited By (2)
US 12,398,410 US 12,435,349